Cargando…
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
Parkinson’s disease (PD) is the second most common neurodegenerative disorder of the elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed most commonly by clinical examination with a great degree of accuracy in specialized centers. However, in some cases, non-cla...
Autores principales: | Ganguly, Upasana, Singh, Sukhpal, Pal, Soumya, Prasad, Suvarna, Agrawal, Bimal K., Saini, Reena V., Chakrabarti, Sasanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298029/ https://www.ncbi.nlm.nih.gov/pubmed/34305577 http://dx.doi.org/10.3389/fnagi.2021.702639 |
Ejemplares similares
-
Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
por: Ganguly, Upasana, et al.
Publicado: (2018) -
Because good enough is never good enough
por: John, M
Publicado: (2012) -
Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012) -
Quality of care: how good is good enough?
por: Chassin, Mark R
Publicado: (2012) -
NOT "Good Enough for the War."
Publicado: (1916)